Literature DB >> 15525433

Structural analysis of Cryptosporidium parvum.

Franz Petry1.   

Abstract

Cryptosporidium parvum (Apicomplexa, formerly Sporozoa) is the causative agent of cryptosporidiosis, an enteric disease of substantial medical and veterinary importance. C. parvum shows a number of unique features that differ from the rest of the class of coccidea in which it is currently grouped taxonomically. Differences occur in the overall structure of the transmission form and the invasive stages of the parasite, its intracellular location, the presence of recently described additional extracellular stages, the host range and target cell tropism, the ability to autoinfection, the nonresponsiveness to anticoccidial drugs, the immune response of the host, and immunochemical and genetic characteristics. These differences have an important impact on the infectivity, the epidemiology, the therapy, and the taxonomy of the parasite. The present article describes the structural analysis of the parasite using light and electron microscopy with an emphasis on structural details unique to C. parvum.

Entities:  

Mesh:

Year:  2004        PMID: 15525433     DOI: 10.1017/S1431927604040929

Source DB:  PubMed          Journal:  Microsc Microanal        ISSN: 1431-9276            Impact factor:   4.127


  13 in total

Review 1.  Interaction forces drive the environmental transmission of pathogenic protozoa.

Authors:  Aurélien Dumètre; Dominique Aubert; Pierre-Henri Puech; Jeanne Hohweyer; Nadine Azas; Isabelle Villena
Journal:  Appl Environ Microbiol       Date:  2011-12-09       Impact factor: 4.792

Review 2.  Infections by Intestinal Coccidia and Giardia duodenalis.

Authors:  Vitaliano A Cama; Blaine A Mathison
Journal:  Clin Lab Med       Date:  2015-04-04       Impact factor: 1.935

3.  Cryptosporidium parvum oocyst viability and behaviour of the residual body during the excystation process.

Authors:  Sirri Kar; Arwid Daugschies; Ayse Cakmak; Nadim Yilmazer; Katja Dittmar; Berit Bangoura
Journal:  Parasitol Res       Date:  2011-05-21       Impact factor: 2.289

4.  Quantitative evaluation of infectivity change of Cryptosporidium parvum after gamma irradiation.

Authors:  Soo-Ung Lee; Mikyo Joung; Taekyoung Nam; Woo-Yoon Park; Jae-Ran Yu
Journal:  Korean J Parasitol       Date:  2009-03-12       Impact factor: 1.341

5.  Evidence for mucin-like glycoproteins that tether sporozoites of Cryptosporidium parvum to the inner surface of the oocyst wall.

Authors:  Anirban Chatterjee; Sulagna Banerjee; Martin Steffen; Roberta M O'Connor; Honorine D Ward; Phillips W Robbins; John Samuelson
Journal:  Eukaryot Cell       Date:  2009-11-30

6.  Significance of wall structure, macromolecular composition, and surface polymers to the survival and transport of Cryptosporidium parvum oocysts.

Authors:  Michael B Jenkins; Barbara S Eaglesham; Larry C Anthony; Scott C Kachlany; Dwight D Bowman; William C Ghiorse
Journal:  Appl Environ Microbiol       Date:  2010-01-22       Impact factor: 4.792

7.  Chemically specific imaging of cryptosporidium oocysts using coherent anti-Stokes Raman scattering (CARS) microscopy.

Authors:  S Murugkar; C L Evans; X S Xie; H Anis
Journal:  J Microsc       Date:  2009-02       Impact factor: 1.758

8.  Multiplication of the waterborne pathogen Cryptosporidium parvum in an aquatic biofilm system.

Authors:  Wan Koh; Peta L Clode; Paul Monis; R C Andrew Thompson
Journal:  Parasit Vectors       Date:  2013-09-19       Impact factor: 3.876

9.  Extracellular excystation and development of Cryptosporidium: tracing the fate of oocysts within Pseudomonas aquatic biofilm systems.

Authors:  Wan Koh; Andrew Thompson; Hanna Edwards; Paul Monis; Peta L Clode
Journal:  BMC Microbiol       Date:  2014-11-18       Impact factor: 3.605

10.  Monoclonal Antibodies to Intracellular Stages of Cryptosporidium parvum Define Life Cycle Progression In Vitro.

Authors:  Georgia Wilke; Soumya Ravindran; Lisa Funkhouser-Jones; Jennifer Barks; Qiuling Wang; Kelli L VanDussen; Thaddeus S Stappenbeck; Theresa B Kuhlenschmidt; Mark S Kuhlenschmidt; L David Sibley
Journal:  mSphere       Date:  2018-05-30       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.